Rare diseases, most often of genetic origin, represent fertile ground for diagnostic and therapeutic innovations. The following two abstracts show how the development of genetic models, artificial intelligence, and computerized patient records are opening up new perspectives for these diseases and public health issues.
Keywords
Computerized patient record, real-life data, OMOP-CDM, federated analysis, artificial intelligence, trusted research environment